Giuseppe Vergaro

giuseppe.vergaro@santannapisa.it
050 883741
Complesso edilizio Sede Centrale

Pubblicazioni

Castiglione, V.; Modena, M.; Aimo, A.; Chiti, E.; Botto, N.; Vittorini, S.; Guidi, B.; Vergaro, G.; Barison, A.; Rossi, A.; Passino, C.; Giannoni, A.; Di Paolo, M.; Emdin, M.

Molecular autopsy of sudden cardiac death in the genomics era Open new browser tab

(2021)
Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M.

The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction Open new browser tab

(2021)
Fabiani, I.; Panichella, G.; Aimo, A.; Grigoratos, C.; Vergaro, G.; Pugliese, N. R.; Taddei, S.; Cardinale, D. M.; Passino, C.; Emdin, M.; Giannoni, A.

Subclinical cardiac damage in cancer patients before chemotherapy Open new browser tab

(2021)
Nicol, M.; Siguret, V.; Vergaro, G.; Aimo, A.; Emdin, M.; Dillinger, J. G.; Baudet, M.; Cohen-Solal, A.; Villesuzanne, C.; Harel, S.; Royer, B.; Arnulf, B.; Logeart, D.

Thromboembolism and bleeding in systemic amyloidosis: a review Open new browser tab

(2021)
Genovesi, D.; Vergaro, G.; Giorgetti, A.; Marzullo, P.; Scipioni, M.; Santarelli, M. F.; Pucci, A.; Buda, G.; Volpi, E.; Emdin, M.

[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions Open new browser tab

(2021)
Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M.

A simple echocardiographic score to rule out cardiac amyloidosis Open new browser tab

(2021)
Passino, C.; Sciarrone, P.; Vergaro, G.; Borrelli, C.; Spiesshoefer, J.; Gentile, F.; Emdin, M.; Giannoni, A.

Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction Open new browser tab

(2021)
Gentile, F.; Aimo, A.; Passino, C.; Emdin, M.; Vergaro, G.

Reply: Natriuretic Peptide-Based Risk Prediction and Assessment of Treatment Effect: Revisited in This Era Open new browser tab

(2021)
Vergaro, G.; Aimo, A.; Taurino, E.; Del Franco, A.; Fabiani, I.; Prontera, C.; Masotti, S.; Musetti, V.; Emdin, M.; Passino, C.

Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure Open new browser tab

(2021)
Cappelli, F.; Tini, G.; Russo, D.; Emdin, M.; Del Franco, A.; Vergaro, G.; Di Bella, G.; Mazzeo, A.; Canepa, M.; Volpe, M.; Perfetto, F.; Autore, C.; Di Mario, C.; Rapezzi, C.; Musumeci, M. B.

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation Open new browser tab

(2021)

Giuseppe Vergaro

Pubblicazioni

Molecular autopsy of sudden cardiac death in the genomics era Open new browser tab

The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction Open new browser tab

Subclinical cardiac damage in cancer patients before chemotherapy Open new browser tab

Thromboembolism and bleeding in systemic amyloidosis: a review Open new browser tab

[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions Open new browser tab

A simple echocardiographic score to rule out cardiac amyloidosis Open new browser tab

Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction Open new browser tab

Reply: Natriuretic Peptide-Based Risk Prediction and Assessment of Treatment Effect: Revisited in This Era Open new browser tab

Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure Open new browser tab

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation Open new browser tab

Corsi

News